Cymabay Drug Patent Portfolio
Cymabay owns 1 orange book drug protected by 6 US patents Given below is the list of Cymabay's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272058 | Treatment of intrahepatic cholestatic diseases | 19 Mar, 2035 | Active |
| US11406611 | Treatment of intrahepatic cholestatic diseases | 19 Mar, 2035 | Active |
| US11596614 | Treatment of intrahepatic cholestatic diseases | 19 Mar, 2035 | Active |
| US9486428 | Treatment of intrahepatic cholestatic diseases | 19 Mar, 2035 | Active |
| US7709682 | Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives | 13 Sep, 2026 | Active |
| US7301050 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | 02 Aug, 2025 | Active |
Cymabay's Family Patents
Cymabay Drug List
Given below is the complete list of Cymabay's drugs and the patents protecting them.
1. Livdelzi
Livdelzi is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272058 | Treatment of intrahepatic cholestatic diseases |
19 Mar, 2035
(10 years from now)
| Active |
| US11406611 | Treatment of intrahepatic cholestatic diseases |
19 Mar, 2035
(10 years from now)
| Active |
| US11596614 | Treatment of intrahepatic cholestatic diseases |
19 Mar, 2035
(10 years from now)
| Active |
| US9486428 | Treatment of intrahepatic cholestatic diseases |
19 Mar, 2035
(10 years from now)
| Active |
| US7709682 | Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives |
13 Sep, 2026
(1 year, 11 months from now)
| Active |
| US7301050 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
02 Aug, 2025
(10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Livdelzi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List